Prognostic Factors of Early Morphological Response to Treatment with Ranibizumab in Patients with Wet Age-Related Macular Degeneration
المؤلفون المشاركون
Kolar, Petr
Dusek, Ladislav
Jarkovsky, Jiri
Chrapek, Oldrich
Chrapkova, Barbora
Sin, Martin
Studnička, Jan
Pitrová, Šárka
Řehák, Jiří
المصدر
العدد
المجلد 2015، العدد 2015 (31 ديسمبر/كانون الأول 2015)، ص ص. 1-4، 4ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2015-03-04
دولة النشر
مصر
عدد الصفحات
4
التخصصات الرئيسية
الملخص EN
Aim.
To assess the significance of age, gender, baseline best corrected visual acuity, baseline macula thickness, and type and size of choroidal neovascularization in early morphological therapeutic response to ranibizumab treatment in patients with the wet form of age-related macular degeneration.
Methods.
From 09/2008 to 06/2013 we evaluated 1153 newly diagnosed, treatment-naïve patients treated with ranibizumab.
Based on the morphological findings in the macula following the initial 3 injections of ranibizumab, the patients were divided into two groups based on active and inactive choroidal neovascularization.
Results.
After the initial 3 injections of ranibizumab, we examined the sample of 841 eyes with active CNV and 312 eyes with inactive CNV.
In the inactive group, we found a statistically higher proportion of occult CNV ( P < 0.001 ) and lower incidence of CNV greater than 5DA ( P < 0.001 ) compared with the active group.
We found no statistically significant difference in age, gender, baseline best corrected visual acuity, or baseline macula thickness between the inactive and active groups.
Conclusion.
Occult CNV and CNV smaller than 5DA are optimistic factors for a better morphological therapeutic response at the beginning of ranibizumab treatment.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Chrapek, Oldrich& Jarkovsky, Jiri& Sin, Martin& Studnička, Jan& Kolar, Petr& Chrapkova, Barbora…[et al.]. 2015. Prognostic Factors of Early Morphological Response to Treatment with Ranibizumab in Patients with Wet Age-Related Macular Degeneration. Journal of Ophthalmology،Vol. 2015, no. 2015, pp.1-4.
https://search.emarefa.net/detail/BIM-1069873
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Chrapek, Oldrich…[et al.]. Prognostic Factors of Early Morphological Response to Treatment with Ranibizumab in Patients with Wet Age-Related Macular Degeneration. Journal of Ophthalmology No. 2015 (2015), pp.1-4.
https://search.emarefa.net/detail/BIM-1069873
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Chrapek, Oldrich& Jarkovsky, Jiri& Sin, Martin& Studnička, Jan& Kolar, Petr& Chrapkova, Barbora…[et al.]. Prognostic Factors of Early Morphological Response to Treatment with Ranibizumab in Patients with Wet Age-Related Macular Degeneration. Journal of Ophthalmology. 2015. Vol. 2015, no. 2015, pp.1-4.
https://search.emarefa.net/detail/BIM-1069873
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1069873
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر